Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum

NCT07509008 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer, Metastatic

Interventions

DRUG: TGFBR2 KO CAR27/IL-15 NK cells
DRUG: Rimiducid (AP1903)
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

M.D. Anderson Cancer Center